semaglutide united states Novo Nordisk cuts some US
Description
Consistent with other GLP-1RAs, the most frequently expected adverse events in individuals receiving semaglutide are GI-related events, such as nausea, vomiting, and diarrhea [38, 60]
doi: 10.1016/j.ijrobp.2011.05.043 [DOI] [PubMed] [Google Scholar] 3
USA 109 , E187E196 (2012)
Equally, an individual's experience may change after the switch
Some experts believe that the drugs effects on people may be related to the role that dopamine, a neurotransmitter, plays in rewarding addictive and compulsive behavior
